DV
Dividend Vision

OBIO — Orchestra BioMed Holdings Inc.

Orchestra BioMed Holdings Inc. (OBIO)

Total return is -61.3% over the past 6 years, 216.7 points behind SPY at 155.4%. Its deepest 1-year drawdown was 34.8%.

Orchestra BioMed Holdings Inc. is an equity fund that focuses on biomedical holdings as a stock-type investment vehicle. The fund lacks a specified distribution frequency and does not currently maintain a measurable distribution rate or expense ratio. This fund may appeal to investors seeking exposure to the biomedical sector, though limited publicly available data on yield profile and fees limits detailed characterization of its income generation potential.

OBIO key facts

Asset type
Stock
Asset class
Equity
Inception date
08/04/2020
Last close
$4.41
Market cap
$220,959,840
Average volume
142800.0
Beta
0.483
Payout ratio
0.0
Forward P/E
0.0
EPS
$-0.94